NDC 68817-134

ABRAXANE

Paclitaxel

ABRAXANE is a Intravenous Injection, Powder, Lyophilized, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Abraxis Bioscience, Llc. The primary component is Paclitaxel.

Product ID68817-134_0727ce20-fbf4-4233-b056-d6a8ab033519
NDC68817-134
Product TypeHuman Prescription Drug
Proprietary NameABRAXANE
Generic NamePaclitaxel
Dosage FormInjection, Powder, Lyophilized, For Suspension
Route of AdministrationINTRAVENOUS
Marketing Start Date2005-02-10
Marketing CategoryNDA / NDA
Application NumberNDA021660
Labeler NameAbraxis BioScience, LLC
Substance NamePACLITAXEL
Active Ingredient Strength100 mg/20mL
Pharm ClassesMicrotubule Inhibition [PE], Microtubule Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 68817-134-50

1 VIAL, SINGLE-USE in 1 CARTON (68817-134-50) > 20 mL in 1 VIAL, SINGLE-USE
Marketing Start Date2005-02-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68817-134-50 [68817013450]

ABRAXANE INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Marketing CategoryNDA
Application NumberNDA021660
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2005-02-10

Drug Details

Active Ingredients

IngredientStrength
PACLITAXEL100 mg/20mL

OpenFDA Data

SPL SET ID:24d10449-2936-4cd3-b7db-a7683db721e4
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 583214
  • 583218
  • UPC Code
  • 0368817134500
  • Pharmacological Class

    • Microtubule Inhibition [PE]
    • Microtubule Inhibitor [EPC]

    NDC Crossover Matching brand name "ABRAXANE" or generic name "Paclitaxel"

    NDCBrand NameGeneric Name
    68817-134ABRAXANEABRAXANE
    0703-3213PaclitaxelPaclitaxel
    0703-3216PaclitaxelPaclitaxel
    0703-3217PaclitaxelPaclitaxel
    0703-3218PaclitaxelPaclitaxel
    0703-4764PaclitaxelPaclitaxel
    0703-4766PaclitaxelPaclitaxel
    0703-4767PaclitaxelPaclitaxel
    0703-4768PaclitaxelPaclitaxel
    16714-137PaclitaxelPaclitaxel
    16729-098PaclitaxelPACLITAXEL
    44567-504PaclitaxelPaclitaxel
    44567-505PaclitaxelPaclitaxel
    44567-506PaclitaxelPaclitaxel
    45963-613PaclitaxelPaclitaxel
    47781-593Paclitaxelpaclitaxel
    24979-710Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)Paclitaxel

    Trademark Results [ABRAXANE]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ABRAXANE
    ABRAXANE
    78415969 3007995 Live/Registered
    ABRAXIS BIOSCIENCE, LLC
    2004-05-10
    ABRAXANE
    ABRAXANE
    78282011 2990396 Live/Registered
    ABRAXIS BIOSCIENCE, LLC
    2003-08-01

    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.